טוען...
Macrophage migration inhibitory factor promotes resistance to glucocorticoid treatment in EAE
OBJECTIVE: Glucocorticoids (GCs) are used as standard treatment for acute attacks of multiple sclerosis (MS). However, GCs eventually lose efficacy and do not prevent disease progression. Macrophage migration inhibitory factor (MIF) is the only known proinflammatory cytokine induced by GCs that inhi...
שמור ב:
| הוצא לאור ב: | Neurol Neuroimmunol Neuroinflamm |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Lippincott Williams & Wilkins
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4529283/ https://ncbi.nlm.nih.gov/pubmed/26280015 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000139 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|